CD38 and systemic lupus erythematosus: Moreover, in patients with systemic lupus erythematodes (SLE) and increased susceptibility to infections, it was shown that CD38 overexpression in CD8+ T cells leads to mitochondrial dysfunctionality accompanied by restricted cytokine production, which could be improved by CD38i treatment.